Sensile Medical

Sensile Medical is a drug delivery technology company developing a wearable injector using its proprietary micro pump. Sensile’s technology allows for programmable micro volumetric delivery of pharmaceutical and biopharmaceutical products, commercialised as a device platform.

Associated Companies

Global Headquarters
Sensile Medical AG
Solothurnerstrasse 235
CH-4600 Olten
Switzerland

Phone / Contact

T: + 41 62 209 71 00
F: + 41 62 209 71 01
E: [email protected]

Connect

Sensile Medical develops a wearable drug delivery device platform technology. Sensile’s technology includes a micro volumetric rotary piston pump, SenseCore, which can precisely dose drug, consists of only two plastic parts and enables programmable delivery profiles.

The company’s patch pump features:

Inherent accuracy
Cost efficient design
Standard vials as primary packaging
Inherent free-flow protection
Small (3 mL) and large (20 mL) versions
Scalability
Needle auto-inserter
Two part device with disposable drug container and reusable electronics.

Sensile Medical was founded in 2004 with the idea of the SenseCore technology and began as a small group of engineers. The company moved from Hägendorf (Switerland) to Olten (Switzerland) in 2017. The company was acquired by Gerresheimer in 2018.

Articles by Sensile Medical

COMPANY SHOWCASE: Sensile Medical

Sensile Medical has achieved a lot since its acquisition by Gerresheimer last year. Here they provide an update on two recent projects: the recent market launch of our first micropump, an infusion pump for Parkinson’s disease patients; and our latest project with SQ Innovation for a 3 mL furosemide patch pump.

CUSTOMISED SOLUTIONS FOR LARGE-VOLUME INJECTORS

Paul Senn discusses the products and philosophy of Sensile Medical, a developer of large volume injection devices utilising a patented micro pump technology.

GETTING TO KNOW SENSILE MEDICAL

Chief Executive Officer Derek Brandt and three of his colleagues – Christoph Lüdi, Head of Systems Engineering, Alex Perrier, Senior Technology Manager, and Marco Drüssel, Mechanical Engineering Manager – have all been a part of Sensile Medical for the past ten years, and here reflect on the company’s past and discuss the future.

BUILDING BRIDGES FROM DRUGS TO PATIENTS: USABILITY & HUMAN FACTORS

Nicolas Sandoz describes Sensile Medical’s approach to ensuring it takes usability and human factors into account during the development of its devices, in particular for subcutaneous delivery.

PREFERRED BY PATIENTS… WITH IMPROVED THERAPIES

Sandra de Haan describes how the Sensile Medical’s micro pump technology advances have enabled it to develop wearable injector patch pumps to deliver better care for patients.

Dr Gerhard Mayer

THE DRIVE UNIT OF THE PATCH PUMP

Gerhard Mayer and Sandra de Haan describe how, together with their pharmaceutical partner scPharmaceuticals (Lexington, MA, US) and Buehler Motor, developed the drive mechanism for a new, soon-to-be launched patch pump.

Dr Gerhard Mayer

A LARGE VOLUME SC DELIVERY SYSTEM MUST ADJUST TO DRUG & PATIENT NEEDS

Here, Gerhard Mayer, Sandra de Haan, and Helmut Thiemer describe the SenseCore micro pump and its advantages when applied in the area of large volume injection devices.

Dr Pieter Muntendam

LARGE-VOLUME INJECTOR ENABLES ANYTIME ANYWHERE DELIVERY OF PARENTERAL DRUGS

Pieter Muntendam and Gerhard Mayer (Sensile Medical USA) and Lars Krinelke (Sensile) describe how their large-volume injection device allows subcutaneous selfadministration.

Top

W3 Total Cache is currently running in Pro version Development mode.